眼科黏弹装置市场规模、份额、成长分析（按产品类型、按应用、按最终用户、按地区）- 产业预测，2025 年至 2032 年

预计 2023 年全球眼科黏弹剂市场价值将达到 105 亿美元，并从 2024 年的 117.2 亿美元增长到 2032 年的 281.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.6%。

随着白内障、青光眼和老龄化黄斑部病变等眼科疾病的发生率不断上升，眼科黏弹剂 (OVD) 市场正在强劲成长。对微创眼科手术的需求不断增长以及黏弹性材料配方的进步是这一市场扩张的驱动力。 OVD 在手术过程中发挥着至关重要的作用，它提供空间、稳定组织并防止视力丧失。由于全球眼科手术激增、医疗保健可及性的改善以及人们对眼科疾病的认识不断提高，预计该市场将会成长。此外，黏度自适应 OVD 越来越多地被采用，特别是在复杂的眼科手术中，因为它们可以有效地消除对多个注射器的需求。总之，这些因素正在推动该产业向前发展。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

眼科黏弹剂装置市场规模（依产品类型及复合年增长率）（2025-2032）

• 市场概览
• 疏水性
• 亲水性
• 组合

眼科黏弹剂装置市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 黏性眼科黏弹剂
• 可分散眼科黏弹剂

眼科黏弹剂装置市场规模：依组件和复合年增长率（2025-2032）

• 市场概览
• 透明质酸钠
• 硫酸软骨素
• 羟丙基甲基纤维素

眼科黏弹装置市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 白内障手术
• 角膜手术
• 青光眼手术
• 屈光矫正手术

眼科黏弹装置市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 门诊手术中心
• 眼科诊所

眼科黏弹剂市场规模（按剂型类型和复合年增长率）（2025-2032）

• 市场概览
• 一次性的
• 多用途

眼科黏弹装置市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

    主要企业简介

    • 爱尔康（瑞士）
    • 博士伦（博士伦医疗）（美国）
    • 卡尔蔡司医疗公司（德国）
    • 强生视力保健公司（美国）
    • 雷纳人工水晶体有限公司（英国）
    • Bohus BIoTech AB（瑞典）
    • Lifecore Biomedical LLC（美国）
    • 豪雅株式会社（日本）
    • 参天製药株式会社（日本）
    • Croma-Pharma GmbH（奥地利）
    • Eyekon Medical Inc.（美国）
    • RUMEX国际公司（美国）
    • Ziemer Ophthalmic Systems AG（瑞士）
    • Ophtechnics Unlimited（印度）
    • 昊海生物科技（中国）
    • Amring Pharmaceutical Inc.（美国）
    • Truviz眼科公司（美国）
    • Cima Technology Inc.（美国）

结论和建议

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 10.5 billion in 2023 and is poised to grow from USD 11.72 billion in 2024 to USD 28.19 billion by 2032, growing at a CAGR of 11.6% during the forecast period (2025-2032).

The ophthalmic viscoelastic devices (OVDs) market is experiencing robust growth fueled by the rising prevalence of eye disorders, including cataracts, glaucoma, and age-related macular degeneration. Increasing demand for minimally invasive eye surgeries, along with advancements in viscoelastic material formulations, is driving this expansion. OVDs play a vital role during surgeries by preserving space, stabilizing tissues, and preventing vision loss. With a surge in ophthalmic surgeries worldwide, improved access to care, and heightened awareness of ocular disorders, the market is set to thrive. Furthermore, the adoption of viscoadaptive OVDs is gaining traction, particularly in complex ocular procedures, due to their efficiency in reducing the need for multiple syringes. Overall, these factors are collectively propelling the industry forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ophthalmic Viscoelastic Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Ophthalmic Viscoelastic Devices Market Segments Analysis

The ophthalmic viscoelastic devices market is segmented into product type, application, end user and region. Based on product type, the market is segmented into cohesive ophthalmic viscoelastic and dispersive ophthalmic viscoelastic. Based on application, the market is segmented into cataract, glaucoma, corneal transplant and vitreoretinal surgery. Based on end user, the market is segmented into hospitals, ophthalmic clinics and others. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is being significantly propelled by the rising occurrence of various eye disorders, including cataracts, glaucoma, and age-related macular degeneration, which correlate closely with an aging demographic and changing lifestyle choices. These conditions frequently require surgical treatments, underscoring the importance of ophthalmic viscoelastic devices that safeguard the eye's sensitive tissues, preserve surgical space, and enhance the overall surgical experience. As the patient population seeking such interventions increases, there is a correspondingly higher demand for superior viscoelastic products, thereby driving the market's growth and presenting opportunities for innovation in this critical healthcare segment.

Restraints in the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market faces a notable challenge due to the high costs associated with advanced devices that utilize innovative materials and improved biocompatibility. This elevated pricing poses a substantial obstacle for hospitals and clinics, particularly in emerging markets or areas with constrained healthcare budgets. As a result, patients in low and middle-income countries often encounter difficulties in accessing these premium products, primarily due to affordability concerns. Consequently, this situation restricts the overall market penetration of advanced ophthalmic viscoelastic devices in these regions, limiting their widespread adoption and use in vital eye care procedures.

Market Trends of the Global Ophthalmic Viscoelastic Devices Market

The Global Ophthalmic Viscoelastic Devices market is witnessing a significant trend towards the integration of artificial intelligence (AI) and digital technologies within surgical workflows. This innovation is enhancing preoperative planning, intraoperative guidance, and postoperative care, particularly in the application of viscoelastic devices. As AI-driven imaging and surgical assistance become more sophisticated, they offer improved precision and reduced risks during procedures, which in turn leads to better surgical outcomes. This synergy is driving increased adoption rates of viscoelastic devices that are compatible with advanced AI systems, positioning the market for robust growth as these technologies become standard in ophthalmic surgery.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Ophthalmic Viscoelastic Devices Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Hydrophobic
• Hydrophilic
• Combination

Global Ophthalmic Viscoelastic Devices Market Size by Type & CAGR (2025-2032)

• Market Overview
• Cohesive Ophthalmic Viscoelastic
• Dispersive Ophthalmic Viscoelastic

Global Ophthalmic Viscoelastic Devices Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Sodium Hyaluronate
• Chondroitin Sulfate
• Hydroxypropyl Methylcellulose

Global Ophthalmic Viscoelastic Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cataract Surgery
• Corneal Surgery
• Glaucoma Surgery
• Refractive Surgery

Global Ophthalmic Viscoelastic Devices Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics

Global Ophthalmic Viscoelastic Devices Market Size by Formulation Type & CAGR (2025-2032)

• Market Overview
• Single-Use
• Multi-Use

Global Ophthalmic Viscoelastic Devices Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • US
  • Canada
• Europe (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Composition, Application, End User, Formulation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Composition, Application, End User, Formulation Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Composition, Application, End User, Formulation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (Bausch Health) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carl Zeiss Meditec AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Vision (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rayner Intraocular Lenses Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bohus Biotech AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifecore Biomedical LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoya Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Santen Pharmaceutical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Croma-Pharma GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eyekon Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RUMEX International Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ziemer Ophthalmic Systems AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ophtechnics Unlimited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haohai Biological Technology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amring Pharmaceutical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Truviz Ophthalmic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cima Technology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations